TWER (TWER) Stock Price & Analysis
TWER (TWER) rose 0.00% to USD 0.01 as of July 25, 2026 at 13:47 UTC, according to Nexqual real-time market data.
TWER last closed at USD 0.01; the session ranged USD 0.02–0.02 on volume of 100 shares. Market capitalization is $3,983, with a 52-week range of USD 0–0.08 (PNK). Source: Nexqual, July 25, 2026 at 13:47 UTC.
Key Statistics (as of July 25, 2026 at 13:47 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.08 |
| Volume | 100 shares |
| Market Cap | $3,983 |
| Exchange | PNK |
Technical Analysis (TWER)
Nexqual's technical model rates TWER "STRONG SELL" based on 1 bullish and 6 bearish signals across 125 daily candles, as of July 25, 2026 at 13:47 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0.02) |
| MACD | -0 (negative) |
Analyst Ratings (TWER)
Wall Street analysts rate TWER "None", per Nexqual as of July 25, 2026 at 13:47 UTC.
| Consensus Rating | None |
|---|
Earnings (TWER)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2016-09-30 | USD -75 vs est -89.25 ▲ beat |
| 2016-06-30 | USD -96.33 vs est -120 ▲ beat |
| 2015-12-31 | USD 150 vs est -195 ▲ beat |
Source: Nexqual, July 25, 2026 at 13:47 UTC.
Financials & Fundamentals (TWER)
| Total Revenue | $24.60M |
|---|---|
| Revenue Growth (YoY) | -11.10% |
| Gross Margin | +76.78% |
| Operating Margin | -18.35% |
| Profit Margin | -41.50% |
| Current Ratio | 0.13 |
| Total Cash | $4.17M |
| Total Debt | $39.34M |
| Free Cash Flow | $-2.75M |
Source: Nexqual, July 25, 2026 at 13:47 UTC.
Financial Health Score (TWER)
Nexqual rates TWER's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:47 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $4M cash vs $39M debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Mixed — No data |
Ownership (TWER)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 394,409 |
| Float | 393,297 |
| Short % of Float | +12.70% |
Source: Nexqual, July 25, 2026 at 13:47 UTC.
Leadership (TWER)
TWER is led by Philip J. Urso (age 66), Founder & Chairman, per Nexqual as of July 25, 2026 at 13:47 UTC.
| Founder & Chairman | Philip J. Urso (age 66) |
|---|---|
| Senior Vice President of Operations | Michael Connors |
| Director of Marketing & Sales Operations | Jason Dennis |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BSPM | Biostar Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| TLOG | TETRALOGIC PHARMACEUTICALS CORP | USD 0 | ▲ 0% |
| BGI | Birks Group Inc. | USD 0.52 | ▼ 6.09% |
| CDTI | CDTI Advanced Materials, Inc. | USD 0.74 | ▲ 4.23% |
| QUIK | QuickLogic Corporation | USD 12.66 | ▼ 8.19% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:47 UTC. This page is informational and not investment advice.